Press-release for stocks

Prices are updated after-hours

approved crawled time : 13:00

save search

CONTEXTLOGIC VOTE UPDATE: Less Than 350,000 Shares Needed to Approve the Proposed Transaction with Qoo10
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
WISH | $4.855 -2.9% -2.99% 960K

| -3.0% | O: -0.6% H: 0.2% C: -2.41%

Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.12 0.19% 0.0% 17K

Health Technology

| 0.19% | O: 0.19% H: 0.28% C: 0.0%
approval for meeting

Illumina's planned divestment of GRAIL approved by the European Commission
Published: 2024-04-12 (Crawled : 13:00) - prnewswire.com
ILMN | $121.18 -4.64% -4.86% 1.6M

Health Technology

| -2.23% | O: -1.3% H: 4.53% C: -1.5%
approved

Astrotech Announces Listing to the GSA as an Approved United States Government Vendor
Published: 2024-04-08 (Crawled : 13:00) - globenewswire.com
ASTC | $9.54 -1.45% -1.47% 1.6K

Electronic Technology

| 1.47% | O: 0.1% H: 6.9% C: 6.9%
approved

Eagle Shareholders Approve Merger With Star Bulk
Published: 2024-04-05 (Crawled : 13:00) - globenewswire.com
SBLK | $23.14 0.22% 0.22% 1.6M

Transportation

| -2.77% | O: 1.22% H: 1.45% C: -0.87%
EGLE D | $62.6 0.0% 2.9M

Transportation

| 0.04% | O: 0.3% H: 1.76% C: -0.52%
star

GAF Energy Receives Miami-Dade County Approval for Solar Roof
Published: 2024-04-03 (Crawled : 13:00) - prnewswire.com
GIC | $41.3 -1.22% 0.0% 48K

Retail Trade

| -8.16% | O: -0.04% H: 0.71% C: -1.05%
energy approval solar roof

Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L
Published: 2024-03-26 (Crawled : 13:00) - globenewswire.com
CELU | $4.34 5.6% 5.3% 45K

| -20.3% | O: 1.52% H: 0.0% C: -5.98%
biovance services approval system

Golden Matrix Stockholders Approve Acquisition of MeridianBet Group
Published: 2024-03-20 (Crawled : 13:00) - globenewswire.com
GMGI | $2.465 -3.71% -3.85% 67K

| -26.76% | O: 3.82% H: 1.7% C: -14.45%
matrix group acquisition

WaveDancer and Firefly Neuroscience, an AI-Driven Brain Health Company, Each Receive Respective Stockholder Approvals for Merger
Published: 2024-03-18 (Crawled : 13:00) - globenewswire.com
WAVD | $2.16 1.89% 1.85% 6.2K

Information

| -27.04% | O: 30.29% H: 32.5% C: -15.25%
health firefly

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
Published: 2024-03-18 (Crawled : 13:00) - globenewswire.com
SCLX | $1.27 -4.51% -4.72% 1M

| -6.57% | O: -0.73% H: 3.31% C: 0.74%
elyxyb drug patent company health approval review treatment canada migraine submission

MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment
Published: 2024-03-12 (Crawled : 13:00) - globenewswire.com
MGRX | $0.221 -8.79% -9.64% 190K

| 54.43% | O: -2.97% H: 18.53% C: 5.15%
kyzatrex fda approved treatment therapy

Elys BMG Group Announces Approval For Grand Central’s H Street Sportsbook in Washington, DC.
Published: 2024-03-07 (Crawled : 13:00) - globenewswire.com
ELYS | $0.15 14.4% 42K

Consumer Services

| -8.95% | O: 1.95% H: 7.83% C: 1.97%
approval group

Crescent Point Receives Approval for Normal Course Issuer Bid
Published: 2024-03-07 (Crawled : 13:00) - prnewswire.com
CPG | $8.51 -2.97% 0.0% 6.6M

Energy Minerals

| 12.57% | O: 0.53% H: 1.32% C: -0.26%
approval crescent

Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgery
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
EYEN | $0.5473 -7.55% -8.17% 1.7M

Health Technology

| -75.89% | O: -2.19% H: 0.0% C: -21.08%
fda ocular approval treatment pharmaceuticals

NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published: 2024-02-29 (Crawled : 13:00) - prnewswire.com
NRBO | $3.61 2.72% 23K

Health Technology

| -31.05% | O: 9.32% H: 6.66% C: 3.45%
da-1726 obesity first approval treatment pharmaceuticals trial

PetVivo Holdings, Inc. Approved to Dual List on Upstream
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
PETV | $0.605 -2.15% 46K

Manufacturing

| -47.88% | O: 0.01% H: 1.69% C: -0.01%
approved

FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
Published: 2024-02-22 (Crawled : 13:00) - globenewswire.com
ICU | $0.6626 -7.59% -8.21% 1.7M

| -54.3% | O: 17.59% H: 0.7% C: -34.9%
fda device kidney approval grants

J&J Wins Bi-Weekly Dosing Approval from FDA for Tecvayli in Multiple Myeloma
Published: 2024-02-21 (Crawled : 13:00) - biospace.com/
JNJ | $147.59 0.05% 0.0% 8.5M

Health Technology